Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial.
BMC Cancer. 2020 May 12;20(1):406. doi: 10.1186/s12885-020-06911-4.
BMC Cancer. 2020.
PMID: 32398040
Free PMC article.
Clinical Trial.
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Zilli T, Dirix P, Heikkilä R, Liefhooghe N, Siva S, Gomez-Iturriaga A, Everaerts W, Otte F, Shelan M, Mercier C, Achard V, Thon K, Stellamans K, Moon D, Conde-Moreno A, Papachristofilou A, Scorsetti M, Gückenberger M, Ameye F, Zapatero A, Van De Voorde L, López Campos F, Couñago F, Jaccard M, Spiessens A, Semac I, Vanhoutte F, Goetghebeur E, Reynders D, Ost P.
Zilli T, et al. Among authors: semac i.
Eur Urol Focus. 2021 Mar;7(2):241-244. doi: 10.1016/j.euf.2020.12.010. Epub 2020 Dec 29.
Eur Urol Focus. 2021.
PMID: 33386290
Free article.
Clinical Trial.
Item in Clipboard
Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells.
Semac I, Palomba C, Kulangara K, Klages N, van Echten-Deckert G, Borisch B, Hoessli DC.
Semac I, et al.
Cancer Res. 2003 Jan 15;63(2):534-40.
Cancer Res. 2003.
PMID: 12543813
Item in Clipboard
Anti-CD20 treatments and the lymphocyte membrane: pathology for therapy.
Borisch B, Semac I, Soltermann A, Palomba C, Hoessli DC.
Borisch B, et al. Among authors: semac i.
Verh Dtsch Ges Pathol. 2001;85:161-6.
Verh Dtsch Ges Pathol. 2001.
PMID: 11894393
Item in Clipboard
Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling.
Shabaana AK, Kulangara K, Semac I, Parel Y, Ilangumaran S, Dharmalingam K, Chizzolini C, Hoessli DC.
Shabaana AK, et al. Among authors: semac i.
Cell Mol Life Sci. 2005 Jan;62(2):179-87. doi: 10.1007/s00018-004-4404-5.
Cell Mol Life Sci. 2005.
PMID: 15666089
Item in Clipboard
Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes.
Lajaunias F, Nitschke L, Moll T, Martinez-Soria E, Semac I, Chicheportiche Y, Parkhouse RM, Izui S.
Lajaunias F, et al. Among authors: semac i.
J Immunol. 2002 Jun 15;168(12):6078-83. doi: 10.4049/jimmunol.168.12.6078.
J Immunol. 2002.
PMID: 12055217
Item in Clipboard
The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells.
Amano H, Amano E, Moll T, Marinkovic D, Ibnou-Zekri N, Martinez-Soría E, Semac I, Wirth T, Nitschke L, Izui S.
Amano H, et al. Among authors: semac i.
J Immunol. 2003 Mar 1;170(5):2293-301. doi: 10.4049/jimmunol.170.5.2293.
J Immunol. 2003.
PMID: 12594250
Item in Clipboard
Cite
Cite